A federal judge denied a bid by CVS Health, Cigna and UnitedHealth Group to block the Federal Trade Commission's pricing case ...
The appointment marks the latest in a spate of leadership changes at CVS as the company’s insurance segment struggles to ...
Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.
CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.
Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.
In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...
CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim ...
Some analysts are more optimistic about CVS’ ability to navigate higher-than-expected medical costs in its insurance unit ...
CVS Health has named Ed DeVaney president of the company's CVS Caremark pharmacy benefits manager business, CVS announced this week. DeVaney ascends to the top post after having been named interim ...
CVS CEO David Joyner just finished his first full quarter at the helm. He spoke with Yahoo Finance about the conservative ...
CVS’s stock soared toward after its quarterly profit beat expectations by the widest margin in more than four years.
Today, CVS Health® (NYSE: CVS) named Ed DeVaney president of the company's CVS Caremark pharmacy benefit management business. He was named interim president in December 2024. DeVaney will report ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results